Description
Product details
Eporise 10000 Injection is a prescription erythropoietin injection used to support red blood cell production in patients with certain forms of anaemia. By stimulating erythropoiesis in the bone marrow, the medicine helps increase the formation of red blood cells when the body's natural erythropoietin response is inadequate. Eporise 10000 IU may be prescribed for anaemia associated with chronic kidney disease (CKD), including selected dialysis patients, and for certain patients experiencing chemotherapy-related anaemia. Erythropoietin therapy may also be considered for anaemia associated with certain HIV treatment regimens, based on clinical assessment. The injection is administered either subcutaneously (SC) or intravenously (IV). The appropriate dose, treatment interval and route are determined by a healthcare professional according to haemoglobin levels, body weight, underlying condition and response to treatment. How Eporise 10000 Works Eporise acts as an erythropoiesis-stimulating agent (ESA). It interacts with erythropoietin-sensitive cells in the bone marrow and promotes their development into mature red blood cells. Because adequate iron is necessary for haemoglobin formation, doctors may evaluate the patient's iron status and recommend supplementation when clinically appropriate. Main Therapeutic Applications Anaemia Associated with Chronic Kidney Disease Healthy kidneys normally contribute to the regulation of red blood cell production through erythropoietin. In chronic kidney disease, this process may become impaired and contribute to reduced haemoglobin levels. Eporise 10000 IU Injection for renal anaemia may be prescribed to stimulate red blood cell formation in suitable CKD patients, including patients receiving dialysis. Treatment requires regular monitoring so that haemoglobin response and other clinical parameters can be assessed. Chemotherapy-Associated Anaemia Cancer chemotherapy can suppress bone marrow function and reduce red blood cell production. In appropriately selected patients, Eporise 10000 may be used as supportive therapy for chemotherapy-induced anaemia. Its purpose is to promote erythropoiesis and assist with haemoglobin management. Whether erythropoietin therapy is appropriate depends on the cancer treatment, haemoglobin level and individual risk factors. Anaemia Associated with Certain HIV Therapies Erythropoietin treatment may also be considered for selected patients who develop anaemia while receiving certain HIV medicines. The underlying cause of anaemia should be evaluated before treatment is initiated. Administration & Usage Eporise 10000 Injection should be administered according to a physician's instructions. Depending on the clinical situation, it can be given: Subcutaneously (under the skin) Intravenously (into a vein) Treatment is generally administered by a doctor, nurse or appropriately trained healthcare professional. Do not self-administer unless specifically instructed and trained by your healthcare provider. Monitoring During Erythropoietin Therapy Patients receiving an EPO 10000 IU injection may require periodic monitoring of haemoglobin, blood pressure and other relevant laboratory parameters. Iron status may also be assessed because iron deficiency can affect the response to erythropoietin treatment. Patients should inform their doctor about existing medical conditions, particularly uncontrolled hypertension, cardiovascular disease or a history of blood-clotting problems, as well as any other medicines they are taking. Possible Side Effects Reported adverse effects associated with erythropoietin therapy may include increased blood pressure, nausea, vomiting, fever, headache, dizziness, tiredness and flu-like symptoms such as body aches. Serious reactions can occur in some patients. Seizures, symptoms suggestive of a blood clot, severe allergic reactions or significant increases in blood pressure require prompt medical attention. Storage & Handling Eporise 10000 Injection should be stored and handled strictly according to the manufacturer's label and prescribing information. Refrigerated storage may be required. The product should not be used if its packaging is damaged or appropriate storage conditions have not been maintained. Important Safety Information Eporise 10000 is a prescription erythropoietin medicine and requires professional medical supervision. Dose adjustments should only be made by the treating physician based on haemoglobin response and the patient's clinical condition.
